Related Experiment Video

Updated: Jul 8, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival

G Xia1, S R Kumar, J P Stein

  • 1Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.

Oncogene
|October 6, 2005
PubMed

Insights

Receptor tyrosine kinase EphB4 is highly expressed in bladder cancer and drives tumor growth, migration, and invasion. Inhibiting EphB4 significantly reduces tumor progression, suggesting its potential as a therapeutic target and prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Receptor tyrosine kinases play crucial roles in cell signaling and cancer development.
  • EphB4, a member of the Eph receptor tyrosine kinase family, has been implicated in various cancers, but its specific role in bladder cancer requires further elucidation.

Purpose of the Study:

  • To investigate the biological function and therapeutic potential of EphB4 in bladder cancer.
  • To determine the expression levels and regulatory mechanisms of EphB4 in bladder cancer cell lines and tissues.

Main Methods:

  • Analysis of EphB4 expression in bladder cancer cell lines and patient specimens.
  • Investigation of EphB4 regulation by gene amplification, EGFR signaling, and p53.
  • Functional studies using EphB4 knockdown via siRNA and antisense oligodeoxynucleotides.
  • In vivo evaluation in a murine tumor xenograft model.

Main Results:

  • EphB4 is highly expressed in bladder cancer cell lines and patient tumors, with elevated levels compared to normal urothelium.
  • EphB4 expression is regulated by EPHB4 gene amplification, EGFR signaling inhibition, and p53 expression.
  • EphB4 knockdown significantly inhibited cell viability, induced apoptosis (caspase-8 activation, bcl-xl downregulation), and reduced migration and invasion.
  • In vivo, EphB4 knockdown led to substantial tumor volume reduction, decreased proliferation, increased apoptosis, and reduced tumor microvasculature.

Conclusions:

  • EphB4 is a key driver of bladder cancer progression, influencing cell viability, apoptosis, migration, invasion, proliferation, and angiogenesis.
  • EphB4 represents a promising therapeutic target for bladder cancer treatment.
  • EphB4 expression may serve as a predictive biomarker for disease outcome in bladder cancer.

More Related Videos

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: